Home » Site-specific Modules » Lymphoma » Abstracting, Coding, & Staging » Extent of Disease Evaluation » Tumor Markers
- Lymphoma
- Introduction
- Anatomy
- Regional Lymph Nodes
- Lymph Chains & Their Drainage Areas
- Lymph Nodes at Surface
- Deep Lymph Nodes
- Lymph Nodes of the Breast and Upper Limb
- Parietal Lymph Nodes of the Thorax
- Visceral Lymph Nodes of the Thorax
- Lymph Nodes of the Lower Thorax
- Deep Nodes of the Abdominal Cavity
- Visceral Nodes of the Abdominal Cavity
- Lymph Nodes of the Large Intestine and Lower Abdomen
- Parietal Nodes of the Pelvis
- Lymph Nodes of the Pelvis
- Lymph Nodes of the Lower Extremity
- Additional Lymph Node Chains
- Synonymous Terms
- Review
- Abstracting, Coding, & Staging
- ICD-O Site Codes
- Morphology & Grade
- Extent of Disease Evaluation
- Staging
- Abstracting Keys
- Treatment
- Hands-on Exercises
Tumor Markers
Key Information
Prognostic (what treatment to use if the tumor should recur)
DNA Studies
- C-myc DNA Amplification
Juxtaposition of this chromosome with a heavy chain immunoglobulin occurs frequently in Burkitt lymphoma and other B-cell lymphomas, as well as breast cancer and acute lymphoblalstic leukemia. - bcl-2 Oncogene Analysis
Diagnostic method to differentiate B-cell and follicular types of lymphomas - Beta-2M (ß-2 Microglobulin)
Elevated levels present in lymphoproliferative disorders - TDT (Terminal-Deoxynucleotidal Transferase)
Differentiates lymphoblastic lymphomas from other non-Hodgkin lymphomas - Ferritin
Elevated levels present in lymphoproliferative disease; may indicate Hodgkin lymphoma or leukemia
Go to the Tumor Markers page of the Diagnostic Tests module for more information.



